Leveragen Inc., a Boston-based biotech company specializing in next-generation genetic models for antibody discovery, today announced a strategic collaboration with Moonlight Bio, a Seattle-based biotech company pioneering advanced T-cell therapies. This partnership aims to develop cutting-edge T-cell therapies to address some of the most challenging and difficult-to-treat cancers.
Kole Roybal is the lead UCSF inventor.